logo

Sophiris Bio Inc. (SPHS)



Trade SPHS now with
  Date
  Headline
6/8/2017 8:06:30 AM Sophiris Bio Says First Patient Dosed In Phase 2b Study Of Topsalysin
3/27/2017 9:04:04 AM Sophiris Bio Q4 Net Loss $0.5 Mln Or $0.02/shr Vs. Net Loss Of $2.5 Mln Or $0.15/shr Prior Year
8/26/2016 4:02:34 PM Sophiris Bio Closes Underwritten Public Offering
5/11/2016 4:04:22 PM Sophiris Bio Closes Public Offering Of $5 Mln
3/23/2016 4:04:24 PM Sophiris Bio Q4 Loss/share $0.15 Vs. Loss $0.31 Year Ago
11/16/2015 4:09:16 PM Sophiris Bio Q3 Loss/share $0.22 Vs. Loss $0.49 Year Ago
11/10/2015 8:19:14 AM Sophiris Bio Phase 3 BPH Study Successfully Meets Primary Endpoint